RS112201728 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Metabolite levels (isobutyrylcarnitine; isobutyrylcarnitine (C4)) | T | OR: 0.49 | 1E-41 | PubMed |
| Betaine levels | T | OR: 0.21 | 4E-29 | PubMed |
| Plasma X-11381 levels in chronic kidney disease | T | OR: 0.23 | 1E-26 | PubMed |
| Plasma suberoylcarnitine (C8-DC) levels in chronic kidney disease | T | OR: 0.3 | 5E-22 | PubMed |
| Urine suberoylcarnitine (C8-DC) levels in chronic kidney disease | T | OR: 0.29 | 5E-20 | PubMed |
| Plasma argininate* levels in chronic kidney disease | T | OR: 0.23 | 5E-20 | PubMed |
| Urine argininate* levels in chronic kidney disease | T | OR: 0.22 | 6E-19 | PubMed |
| N-acetylarginine levels | T | OR: 0.17 | 2E-18 | PubMed |
| Serum metabolite levels | T | OR: 0.57 | 8E-18 | PubMed |
| Plasma adipoylcarnitine (C6-DC) levels in chronic kidney disease | T | OR: 0.2 | 3E-15 | PubMed |
| Plasma acisoga levels in chronic kidney disease | T | OR: 0.2 | 2E-14 | PubMed |
| Plasma levulinoylcarnitine levels in chronic kidney disease | T | OR: 0.33 | 7E-14 | PubMed |
| Urine X-24470 levels in chronic kidney disease | T | OR: 0.26 | 8E-14 | PubMed |
| Docosahexaenoic acid to total fatty acids percentage | T | — | 2E-13 | PubMed |
| Urine adipoylcarnitine (C6-DC) levels in chronic kidney disease | T | OR: 0.18 | 3E-13 | PubMed |
| Plasma 1-methylnicotinamide levels in chronic kidney disease | T | OR: 0.21 | 3E-12 | PubMed |
| Polyunsaturated fatty acids to monounsaturated fatty acids ratio | T | — | 5E-12 | PubMed |
| Polyunsaturated fatty acids to monounsaturated fatty acids ratio | T | — | 8E-12 | PubMed |
| Monounsaturated fatty acids to total fatty acids percentage | T | — | 2E-11 | PubMed |
| Cholesterol to Total Lipids in Small LDL percentage | T | β: 0.037 | 3E-11 | PubMed |